Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial - Kappos,L.; Comi,G.; Panitch,H. (Nat Med, 2000)